Clinuvel Pharmaceuticals Limited has released a press release.
Update on North American vitiligo program for SCENESSE
Filed with ASX ·
Watch Clinuvel Pharmaceuticals' latest callClinuvel Pharmaceuticals (ASX:CUV) Q4 2026 Earnings Call · Replay · Aug 27Read the transcript of Clinuvel Pharmaceuticals (ASX:CUV) Q4 2026 Earnings Call6ix hasn’t read this filing yet.
Clinuvel Pharmaceuticals Limited on 6ix
Later from Clinuvel Pharmaceuticals
- US FDA orphan designation received for cutaneous porphyrias
- Clinuvel brief on European commercialisation
- Clinuvel Placement
- Clinuvel accredits first European EPP expert centres
- Clinuvel enters a joint venture with Biotech Lab Singapore
Follow Clinuvel Pharmaceuticals into a list and get an email when it puts out news.
Follow Clinuvel Pharmaceuticals